# LEMAITRE VASCULAR INC (LMAT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from LEMAITRE VASCULAR INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/LMAT/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-073360 (https://www.sec.gov/Archives/edgar/data/1158895/000119312526073360/ck0001158895-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/LMAT/mda/fy2024/): filed 2025-02-28; accession 0001437749-25-005637 (https://www.sec.gov/Archives/edgar/data/1158895/000143774925005637/lmat20241231_10k.htm)
- [FY 2023 MD&A](/company/LMAT/mda/fy2023/): filed 2024-02-29; accession 0001437749-24-006037 (https://www.sec.gov/Archives/edgar/data/1158895/000143774924006037/lmat20231231_10k.htm)
- [FY 2022 MD&A](/company/LMAT/mda/fy2022/): filed 2023-03-01; accession 0001437749-23-005056 (https://www.sec.gov/Archives/edgar/data/1158895/000143774923005056/lmat20221231_10k.htm)
- [FY 2021 MD&A](/company/LMAT/mda/fy2021/): filed 2022-02-28; accession 0001437749-22-004662 (https://www.sec.gov/Archives/edgar/data/1158895/000143774922004662/lmat20211231_10k.htm)

Back to /company/LMAT/